We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Neurocrine Biosciences (NBIX)
An SI Board Since July 1996
Posts SubjectMarks Bans Symbol
1834 76 0 NBIX
Emcee:  Billy Dunn Type:  Unmoderated
This is one hot stock to watch. Late yesterday (7-17-96) there was a major uptick and massive buying power moving into this stock.
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1834NBIX trial for Tourette's fails to reach primary end-point, Mullen-12/12/2018
1833AAN 2016 PL02.003 - KINECT 3: A Randomized, Double-Blind, Placebo-Controlled Phatnsaf-3/5/2016
1832Per Jason Napodano, now at Zack's, Solstice will finish third quarter this ytuck-5/7/2015
1831I think that their plan is to report more detail results only when both trials aMiljenko Zuanic-5/7/2015
1830At which scientific meeting might AbbVie disclose the numbers for Violet Petal? tuck-5/5/2015
1829I had suggested to a colleague that a friend of hers try to go on the Elagolix tBiotech Jim-1/12/2015
1828First PIII Elagolix data: There is no break-up of the data Miljenko Zuanic-1/8/2015
1827VMAT2 inhibitor shows positive results in Kinect @ study: Biotech Jim-1/6/2014
1826nice that you have escaped the upswing from 8 to 7:-) looks good but it has beendr.praveen-6/8/2012
1825Ditto your post below, except that I don't have NBIX in the charity portfoliDewDiligence_on_SI-6/8/2012
1824Hello Doc- Even though I have NBIX in the Biotech Charity contest, I currently Biotech Jim-6/8/2012
1823Abbott Announces Initiation of Phase 3 Study of Elagolix in Patients with Endomedr.praveen-6/7/2012
1822VMAT2 PS: I own somedr.praveen-2/29/2012
1821NBIX granted fast track status by the FDA for the VMAT2 program: phx.corporate-Biotech Jim-1/27/2012
1820NBIX announces secondary offering... phx.corporate-ir.netBiotech Jim-1/18/2012
1819Thanks, BJ—good info. Regards, DewDewDiligence_on_SI-1/18/2012
1818Not much detail on Elagolix via the spoken word. More on the VMAT2 program. HereBiotech Jim11/18/2012
1817Did they talk about Elagolix in any detail?DewDiligence_on_SI-1/13/2012
1816Thanks BJ. In their JPM presentation, the company hinted that they had hopes thBiomaven-1/13/2012
1815I have followed the VMAT2 area since the cloning of the protein by Beth Hoffman&Biotech Jim-1/12/2012
1814HI Jim - You have any comments on NBIX's VMAT2 program? Seems like an intriBiomaven-1/12/2012
1813Wylie Vale, founder of NBIX and hormone biochemist from the Salk Institute, passBiotech Jim-1/8/2012
1812more lampert buyingmopgcw-10/14/2011
1811lampert buying here.mopgcw-10/12/2011
1810anyone buying here?mopgcw-8/9/2011
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):